We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+4.81%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$15.6B
AUM Growth
-$328M
Cap. Flow
-$1B
Cap. Flow %
-6.44%
Top 10 Hldgs %
10.08%
Holding
1,228
New
88
Increased
194
Reduced
449
Closed
75

Sector Composition

Rank Sector Weight
1 Industrials 17.91%
2 Communication Services 13.88%
3 Utilities 11.67%
4 Financials 9.82%
5 Consumer Discretionary 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPAQW
1076
DELISTED
Gordon Pointe Acquisition Corp. Warrant
GPAQW
$50K ﹤0.01%
146,100
RMTI icon
1077
Rockwell Medical
RMTI
$26.2M
$49K ﹤0.01%
+147
New +$74.7K
IRIX icon
1078
IRIDEX
IRIX
$15.5M
$46K ﹤0.01%
10,000
BRPM.WS
1079
DELISTED
B. Riley Principal Merger Corp. Warrants, each whole warrant exercisable for one share of Class A co
BRPM.WS
$45K ﹤0.01%
+90,372
New +$55.4K
SNAXW
1080
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$43K ﹤0.01%
+206,400
New +$47.7K
NBRV
1081
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$43K ﹤0.01%
70
TRNE.WS
1082
DELISTED
Trine Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A
TRNE.WS
$38K ﹤0.01%
+50,500
New +$34.8K
ASCMA
1083
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$38K ﹤0.01%
35,100
+22,100
+170% +$20.1K
EVC icon
1084
Entravision Communication
EVC
$983M
$31K ﹤0.01%
10,000
-10,000
-50% -$30.4K
VLRX
1085
DELISTED
VALERITAS HOLDINGS INC
VLRX
$31K ﹤0.01%
11,996
+8,499
+243% +$40.9K
GVP
1086
DELISTED
GSE Systems, Inc.
GVP
$30K ﹤0.01%
1,300
-1,200
-48% -$29.5K
EMWP
1087
DELISTED
Eros Media World PLC
EMWP
$27K ﹤0.01%
1,000
-100
-9% -$13.5K
LRMR icon
1088
Larimar Therapeutics
LRMR
$416M
$26K ﹤0.01%
+1,833
New +$48.8K
ISEE
1089
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$26K ﹤0.01%
20,000
+6,000
+43% +$8.23K
RVPHW
1090
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$25K ﹤0.01%
118,200
TKKSR
1091
DELISTED
TKK Symphony Acquisition Corporation Right
TKKSR
$23K ﹤0.01%
127,040
TTOO
1092
DELISTED
T2 Biosystems, Inc
TTOO
$22K ﹤0.01%
+3
New +$35.1K
TKKSW
1093
DELISTED
TKK Symphony Acquisition Corporation Warrant
TKKSW
$17K ﹤0.01%
127,040
TTPH
1094
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$14K ﹤0.01%
1,500
-2,600
-63% -$47.8K
AKAO
1095
DELISTED
Achaogen Inc
AKAO
$4K ﹤0.01%
195,000
-65,000
-25% -$22.1K
ADNT icon
1096
Adient
ADNT
$1.6B
-15,162
Closed -$196K
ANGO icon
1097
AngioDynamics
ANGO
$562M
-29,000
Closed -$663K
AXGN icon
1098
Axogen
AXGN
$2.1B
-9,600
Closed -$202K
BMY icon
1099
CALL
Bristol-Myers Squibb
BMY
$127B
-100
Closed -$7.09M
BMY icon
1100
PUT
Bristol-Myers Squibb
BMY
$127B
-100
Closed -$2.65M

Similar funds

Gabelli Funds's Q2 2019 Portfolio in Review

As of Q2 2019, Gabelli Funds held 1,228 positions worth $15.6B, down 2.1% from $15.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Gabelli Funds withdrew a net $1B in Q2 2019, closing 75 positions and reducing 449 holdings. Its most notable exit was ARRIS International plc Ordinary Shares, an estimated $93.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Communication Services and Utilities.

Against the trend, Gabelli Funds opened a new position in Navistar International worth $93.5M.

  • Gabelli Funds's largest Q2 2019 buy was Navistar International: 2,713,300 shares worth $93.5M.
  • Gabelli Funds added most to Anadarko Petroleum in Q2 2019, an estimated $37.1M increase.
  • Gabelli Funds's biggest Q2 2019 reduction was O'Reilly Automotive, cutting an estimated $32.3M.
  • Gabelli Funds fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $93.4M.
  • Gabelli Funds's ten largest holdings make up 10% of its $15.6B portfolio in Q2 2019.
  • Gabelli Funds opened 88 new positions and closed 75 in Q2 2019.
  • Gabelli Funds's portfolio value fell 2.1% quarter-over-quarter to $15.6B.

Based on Gabelli Funds's 13F filing for Q2 2019, filed 2 Aug 2019.